NovaBridge Biosciences (NBP) Other Gross PP&E Adjustments (2018 - 2025)

NovaBridge Biosciences (NBP) has 8 years of Other Gross PP&E Adjustments data on file, last reported at -$4.1 million in Q4 2025.

• Quarterly Other Gross PP&E Adjustments rose 13.7% year-over-year to -$4.1 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$4.1 million (up 13.7% YoY) and the FY2025 annual result came in at -$4.1 million, up 13.7% from the prior year.
• Other Gross PP&E Adjustments declined to -$4.1 million in Q4 2025 per NBP's latest filing, from -$2.9 million in the prior quarter.
• Across five years, Other Gross PP&E Adjustments topped out at $8.5 billion in Q4 2022 and bottomed at -$10.5 billion in Q4 2021.
• The 5-year median for Other Gross PP&E Adjustments is -$3.2 million (2021), against an average of $232.9 million.
• The widest annual swing landed in 2021, when Other Gross PP&E Adjustments sank 677472.93%; it then soared 181.19% in 2022.
• Tracing NBP's Other Gross PP&E Adjustments over 5 years: stood at -$10.5 billion in 2021, then soared by 181.19% to $8.5 billion in 2022, then slumped by 40.93% to $5.0 billion in 2023, then tumbled by 100.1% to -$4.8 million in 2024, then advanced by 13.7% to -$4.1 million in 2025.
• Per Business Quant, the three latest NBP Other Gross PP&E Adjustments figures stand at -$4.1 million (Q4 2025), -$2.9 million (Q3 2025), and -$3.0 million (Q2 2025).

Peer Comparison